Tonix Pharmaceuticals Holding Corp.

11/17/2026 | Press release | Distributed by Public on 11/17/2026 10:18

TNX-4800 for Lyme Disease Prevention in the U.S.

Tonix Pharmaceuticals Holding Corp. published this content on November 17, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 17, 2026 at 16:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]